OPRT:NASDAQOportun Financial Corporation Analysis
Data as of 2026-04-22 - not real-time
$5.74
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Oportun Financial (OPRT) is trading at $5.74, well below its DCF‑derived fair value of $59.05, implying an upside of roughly 38% and positioning the stock as significantly undervalued. The technical picture is mixed: the 20‑day SMA ($5.02) sits just above the 50‑day SMA ($4.98) while both remain below the 200‑day SMA ($5.55), suggesting a neutral longer‑term trend, yet the MACD histogram is positive (0.12) and the MACD line ($0.25) exceeds its signal ($0.13), delivering a bullish signal. Momentum remains strong with an RSI of 67, indicating continued buying pressure but approaching overbought territory.
Recent earnings highlight a turnaround: the company posted GAAP EPS of $0.53 for 2025 and an adjusted EPS of $1.36, an 89% YoY increase, alongside a gross margin of 95% and operating margin of 10.7%. Leadership has shifted to interim co‑CEOs Kate Layton and Gaurav Rana, introducing short‑term governance uncertainty but also an opportunity for strategic realignment. Despite a high beta (~2.1) and 30‑day volatility near 60%, volume remains stable, and the balance sheet shows ample cash ($104M) against a large debt load, resulting in a very high debt‑to‑equity ratio. Overall, the combination of deep valuation discount, recent profitability, and bullish technical cues outweighs the heightened risk profile.
Recent earnings highlight a turnaround: the company posted GAAP EPS of $0.53 for 2025 and an adjusted EPS of $1.36, an 89% YoY increase, alongside a gross margin of 95% and operating margin of 10.7%. Leadership has shifted to interim co‑CEOs Kate Layton and Gaurav Rana, introducing short‑term governance uncertainty but also an opportunity for strategic realignment. Despite a high beta (~2.1) and 30‑day volatility near 60%, volume remains stable, and the balance sheet shows ample cash ($104M) against a large debt load, resulting in a very high debt‑to‑equity ratio. Overall, the combination of deep valuation discount, recent profitability, and bullish technical cues outweighs the heightened risk profile.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD crossover with positive histogram
- RSI indicating strong momentum
- Current price above short‑term support (≈$4.33)
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained GAAP profitability and EPS growth
- Significant valuation gap to DCF fair value
- Strategic expense reductions improving margins
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term undervaluation with 38% upside potential
- Mission‑driven niche in credit services with high gross margins
- Potential for leadership stabilization and strategic growth
Key Metrics & Analysis
Financial Health
Revenue Growth7.10%
Profit Margin3.48%
P/E Ratio10.8
ROE6.79%
ROA0.78%
Debt/Equity720.61
P/B Ratio0.7
Op. Cash Flow$413.4M
Industry P/E17.6
Technical Analysis
TrendNeutral
RSI67.6
Support$4.33
Resistance$6.14
MA 20$5.02
MA 50$4.98
MA 200$5.55
MACDBullish
VolumeStable
Fear & Greed Index86.96
Valuation
Fair Value$59.05
Target Price$7.92
Upside/Downside37.92%
GradeUndervalued
TypeBlend
Risk Assessment
Beta2.08
Volatility59.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.